We are obsessed with increasing efficiency in drug discovery. We want to break the traditional approach to identifying chemical starting points and lead molecules targeting membrane proteins. We want to enable rapid development of new therapies that were previously out of reach, making the impossible possible, helping improve the lives of patients.
Our team of drug hunters posses years of technical expertise in membrane protein drug discovery. From target validation to lead optimization to DC selection, and execution of pre-clinical studies, all the way into human clinical trials.
We have trained in Nobel Laureate labs, and have previously invented methods that revolutionized the field of GPCR drug discovery. We have worked tirelessly to introduce novel technology that facilitated lead optimization and membrane protein drug discovery, leading to multiple candidates evaluated in the clinic, and strive to continue to deliver.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.